Employers recently joined the chorus about drug pricing reform, calling for drastic changes. Recently, nearly 40 employer and health groups teamed, sending a letter to Congress calling for legislation to revamp drug pricing.
read full article ›A recent Kaiser Family Foundation survey suggests 3 reasons: (1) Seeing millions of Americans safely vaccinated, (2) Hearing the message from trusted experts, and (3) Learning that vaccination will open opportunities to participate in activities, like travel.
read full article ›Real Endpoints President Susan Raiola contributed to this insightful piece on what payers and patients are looking for in additional value criteria. Payers, perhaps unsurprisingly, see value in treatments that provide tangible benefits, such as a addressing an unmet need. Patients, on the other hand, are looking towards the future, with an emphasis placed on the value of hope.
read full article ›Real Endpoints Marketplace for addressing high-cost orphan medical benefit drugs is included in MIT’s white paper on emerging market solutions
read full article ›Last week’s FDA approval of Aduhelm put the debate about sustainable, affordable access to innovation front and center. We surveyed
read full article ›An important piece from the inaugural Chief Health Equity Officer at Humana, Nwando Olayiwola, M. D., on the need for health
read full article ›May is #MentalHealthMonth Great piece in New York Times highlighting the expanding role that retail pharmacy providers will play in providing
read full article ›The pharmaceutical industry faces a large and ugly problem: the growing economic burden on their payer customers of specialty drugs.
read full article ›